Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. We believe there's a better way to safely and effectively bring real relief to patients, advancing accessible therapies to prescribers and payers, and providing peace of mind to parents and caregivers.
Verrica is focused on innovation, changing the narrative around viral skin diseases, and making treatment a more efficient process for both physicians and patients. Verrica Pharmaceuticals is committed to the development and commercialization of novel treatments that provide significant benefit for people living with skin diseases.
Verrica is focused on innovation, changing the narrative around viral skin diseases, and making treatment a more efficient process for both physicians and patients. Verrica Pharmaceuticals is committed to the development and commercialization of novel treatments that provide significant benefit for people living with skin diseases.
Services
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. We believe there's a better way to safely and effectively bring relief to patients, deliver peace of mind to parents and caregivers, and advance accessible therapies to prescribers and payers.
Developing innovative, safe and effective therapies is a challenge. Experience matters. Our Leadership Team comprises successful, seasoned executives, who benefit from the support, collaboration and insight from the Board of Directors to accelerate the pipeline and maximize the potential for successful outcomes.
Verrica Pharmaceuticals Inc. (Verrica) is dedicated to furthering the education of healthcare professionals with high-quality medical education programs through our Medical Education Grant Funding Committee. These programs contribute to disease awareness and patient care in the areas in which Verrica has interests.
Verricas lead product candidate, VP-102, is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin (0.7% w/v) delivered via a single-use applicator that allows for precise topical dosing and targeted administration. We are developing VP-102 for the treatment of molluscum contagiosum (molluscum), common warts and external genital warts, three of the most common viral skin diseases in medical dermatology.
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. We believe there's a better way to safely and effectively bring real relief to patients, advancing accessible therapies to prescribers and payers, and providing peace of mind to parents and caregivers.
Reviews
Be the first to review Verrica Pharmaceuticals.
Write a Review
